Eurosurv. Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020

[tetano]

• Repeated leftover serosurvey of SARS-CoV-2 IgG antibodies, Greece, March and April 2020
  
  
• Zacharoula Bogogiannidou[SUP]1[/SUP] , Alexandros Vontas[SUP]1[/SUP] , Katerina Dadouli[SUP]1[/SUP] , Maria A Kyritsi[SUP]1[/SUP] , Soteris Soteriades[SUP]1[/SUP] , Dimitrios J Nikoulis[SUP]1[/SUP] , Varvara Α Mouchtouri[SUP]1[/SUP] , Michalis Koureas[SUP]1[/SUP] , Evangelos I Kazakos[SUP]2[/SUP] , Emmanouil G Spanos[SUP]1[/SUP] , Georgia Gioula[SUP]3[/SUP] , Evangelia E Ntzani[SUP]4,5,6[/SUP] , Alexandros A Eleftheriou[SUP]4[/SUP] , Alkiviadis Vatopoulos[SUP]7[/SUP] , Efthimia Petinaki[SUP]8[/SUP] , Vassiliki Papaevangelou[SUP]9[/SUP] , Matthaios Speletas[SUP]10[/SUP] , Sotirios Tsiodras[SUP]11[/SUP] , Christos Hadjichristodoulou[SUP]1[/SUP]

A serosurvey of IgG antibodies against severe acute respiratory coronavirus 2 (SARS-CoV-2) was performed during March and April 2020. Among 6,586 leftover sera, 24 (0.36%) were positive, with higher prevalence in females, older individuals and residents of large urban areas. Seroprevalence was estimated at 0.02% and 0.25%, respectively, in March and April, infection fatality rate at 2.66% and 0.54%. Our findings confirm low COVID-19 incidence in Greece and possibly the effectiveness of early measures.

full article

https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.31.2001369#html_fulltext